Loading...
Images of Vern Bowles
(0 from 0 )News
Successful Completion of Hatchtech's Phase 2b Clinical Trial in Head...
www.finanznachrichten.de
DeOvo™ demonstrates safety and clear efficacy against head lice and their eggs from one single application and is now positioned to accelerate into Phase 3.
| Boral
www.boral.com
Getting Into the European Market When Kean took over from Neal, Boral had small operations in the United Kingdom that it had acquired in the takeover of...
HATCHTECH RAISES $6.3M FOR DeOvo? HEAD LICE PHASE 2b CLINICAL TRIAL -...
www.gbsventures.com.au
Array
BioWorkshop – Ask Industry Anything | BioMelbourne Network
biomelbourne.org
Dr Vern Bowles, CSO, Hatchtech Pty Ltd Dr Megan Baldwin, CEO & Managing Director, Opthea Limited Paul Brennan, CEO, PolyNovo Limited Mrs Lusia Guthrie, Chairman Clever Culture Systems AG, Experienced CEO and Industry Expert, and Deputy Chair of BioMelbourne Network Dr Matt Harris, CEO, ...
sorted by relevance / date